Commentary on "the risky business of studying prognosis"

Anna Broder; Chaim Putterman

doi:10.3899/jrheum.130393

Commentary on "the risky business of studying prognosis"

Anna Broder
, Chaim Putterman

Albert Einstein College of Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	1771
Number of pages	1
Journal	Journal of Rheumatology
Volume	40
Issue number	10
DOIs	https://doi.org/10.3899/jrheum.130393
State	Published - Oct 2013
Externally published	Yes

Funding

Funders	Funder number
National Institute of Diabetes and Digestive and Kidney Diseases	R01DK090319
National Institute of Arthritis and Musculoskeletal and Skin Diseases	R01AR048692

Access to Document

10.3899/jrheum.130393

Cite this

@article{ac0b5446884c48508d7401373e3d9e0b,

title = "Commentary on {"}the risky business of studying prognosis{"}",

author = "Anna Broder and Chaim Putterman",

year = "2013",

month = oct,

doi = "10.3899/jrheum.130393",

language = "אנגלית",

volume = "40",

pages = "1771",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "10",

}

TY - JOUR

T1 - Commentary on "the risky business of studying prognosis"

AU - Broder, Anna

AU - Putterman, Chaim

PY - 2013/10

Y1 - 2013/10

UR - https://www.scopus.com/pages/publications/84885108175

U2 - 10.3899/jrheum.130393

DO - 10.3899/jrheum.130393

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 24085758

AN - SCOPUS:84885108175

SN - 0315-162X

VL - 40

SP - 1771

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 10

ER -

Commentary on "the risky business of studying prognosis"

Funding

Access to Document

Other files and links

Cite this